Results 81 to 90 of about 5,663,674 (349)

The Challenge of Conflict of Interest in Medicine [PDF]

open access: yes, 2013
The expanding relationships between industry and medicine have produced great benefits. Industry support for medical research has led to important therapeutic breakthroughs. Such support has helped medical education at all levels.
Thompson, Dennis F.
core   +1 more source

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

open access: yesMolecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen   +13 more
wiley   +1 more source

CONFLICT OF INTEREST: A CRITICAL ANALYSIS OF FRANCHISING BUSINESS [PDF]

open access: yes
There are many multinational companies engaging with the franchising mechanisms in order to expand the business opportunity, to explore new opportunities, and to develop businesses domestically and internationally.
Hassanudin Bin Mohd Thas Thaker
core  

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Analysts' Conflict of Interest and Biases in Earnings Forecasts [PDF]

open access: yes
Analysts' earnings forecasts are influenced by their desire to win investment banking clients. We hypothesize that the equity bull market of the 1990s, along with the boom in investment banking business, exacerbated analysts' conflict of interest and ...
Jason Karceski   +2 more
core  

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Addressing conflict of interest in non‐pharmacological research

open access: yesInternational journal of clinical practice, 2015
Conflicts also occur due to bias arising from the need for people to be successful in financial and scientific terms (5). Similarly conflicts of interest in non-pharmacological (N-Ph) research are not uncommon, and are equally damaging to the quality of ...
A. Clark   +3 more
semanticscholar   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy